Coverage
-
October 31, 2018
A New Jersey federal judge on Tuesday paused his Friday order that invalidated a patent covering Janssen Biotech Inc.'s blockbuster oncology medication Zytiga, allowing the company to appeal the opinion to the Federal Circuit.
1 other articles on this case.
View all »